Data Science & AI

New Whitepaper: Preventing High-Cost Emergency Care Through Predictive Models for Medicaid Population Health

Recap: Putting Care at the Center 2025

How AI can help bring better care to Medicaid patients

Many Medicaid patients have fragmented, disorganized records that make it hard to provide them care. Carefully designed AI can help.

Explainer: Waymark’s Impact on Patient Care and Cost Savings

Waymark Named One of Business Insider’s Most Promising Healthcare Startups of 2024

This nomination acknowledges Waymark’s approach to leveraging AI/ML technologies to deliver precise care to patients receiving Medicaid.

The Risk of Perpetuating Health Disparities through Cost-Effectiveness Assessments

In a new peer-reviewed study just published in Health Affairs, Waymark co-founder and Head of Clinical Sanjay Basu and co-authors at the University of Pennsylvania and University of California San Francisco explore how cost-effective analyses—one of the most commonly used tools to evaluate health interventions—may risk perpetuating health disparities.

From Veneers To Value: Data Science Can Enable High-Value Care In Medicaid

In a new article for Health Affairs, Waymark co-founders Rajaie Batniji and Sanjay Basu and VP of Data Science and AI Sadiq Patel discuss how data quality issues and insufficient integration of clinical and social risk factor data have limited the ability of Medicaid programs to proactively identify and deliver targeted interventions to at-risk patients.

Recap: AcademyHealth Annual Research Meeting

Waymark’s Data Science team, led by Sadiq Patel and Bhairavi Muralidharan, were in attendance at Academy Health's Annual Research Meeting. These are their top takeaways.

Reaching Patients in the Critical Moment: Waymark’s Approach to AI & Rising Risk

For many rising risk patients, there is often a critical window of time to reach and engage them before their health changes for the worse — and they end up in the ED or hospital as a result. Rather than focusing solely on addressing the needs of high-cost claimants, we prioritize reaching and engaging rising risk patients before they cross into that category.

The Randomized Trials That Underpin Waymark's Care Model

Randomized controlled trials (RCTs) are the gold standard for identifying the strongest evidence for clinical practice. At Waymark, we rely on rigorous RCTs to define the detailed protocols and processes we deploy as our care model.